Volume 20, Number 4—April 2014
CME ACTIVITY - Research
Travel-associated Antimicrobial Drug–Resistant Nontyphoidal Salmonellae, 2004–2009
Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at www.medscape.org/journal/eid; (4) view/print certificate.
Release date: March 18, 2014; Expiration date: March 18, 2015
Upon completion of this activity, participants will be able to:
• Describe the epidemiology and clinical characteristics of nontyphoidal Salmonella (NTS) infections
• Distinguish antibiotic resistance associated with NTS cases in Oregon between 2004 and 2009
• Identify factors positively and negatively associated with antibiotic resistance among NTS cases in Oregon between 2004 and 2009.
P. Lynne Stockton-Taylor, DVM, MA, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Carol E. Snarey, MA, has disclosed no relevant financial relationships.
Laurie Barclay, MD, freelance writer and reviewer, Medscape, LLC. Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.
Disclosures: Russell S. Barlow, MPH; Emilio E. DeBess, DVM, MPVM; Jodi A. Lapidus, PhD; Robert Vega, MS(SM,AAM); and Paul R. Cieslak, MD, have disclosed no relevant financial relationships. Kevin L. Winthrop, MD, MPH, has disclosed the following relevant financial relationships: served as an advisor or consultant for Pfizer, UCB, Genentech, AbbVie, Regeneron; received grants for clinical research from Pfizer.
Comments to the EID Editors
Please contact the EID Editors via our Contact Form.
- Page created: March 18, 2014
- Page last updated: March 18, 2014
- Page last reviewed: March 18, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)